Caxton Associates (New York)’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $376K | Buy |
+2,490
| New | +$376K | 0.01% | 376 |
|
|
2023
Q4 | – | Sell |
-1,773
| Closed | -$216K | – | 478 |
|
|
2023
Q3 | $216K | Buy |
+1,773
| New | +$216K | 0.03% | 348 |
|
|
2021
Q2 | – | Sell |
-5,065
| Closed | -$650K | – | 465 |
|
|
2021
Q1 | $650K | Buy |
+5,065
| New | +$650K | 0.06% | 101 |
|
|
2019
Q1 | – | Sell |
-4,680
| Closed | -$390K | – | 388 |
|
|
2018
Q4 | $390K | Buy |
+4,680
| New | +$390K | 0.06% | 133 |
|
|
2018
Q1 | – | Sell |
-9,973
| Closed | -$982K | – | 306 |
|
|
2017
Q4 | $982K | Buy |
9,973
+3,273
| +49% | +$322K | 0.05% | 164 |
|
|
2017
Q3 | $627K | Buy |
6,700
+700
| +12% | +$65.5K | 0.02% | 212 |
|
|
2017
Q2 | $667K | Sell |
6,000
-700
| -10% | -$77.8K | 0.03% | 175 |
|
|
2017
Q1 | $658K | Buy |
+6,700
| New | +$658K | ﹤0.01% | 139 |
|